Literature DB >> 12527662

Assessment of myocardial perfusion abnormalities by intravenous myocardial contrast echocardiography with harmonic power Doppler imaging: comparison with positron emission tomography.

T Muro1, T Hozumi, H Watanabe, H Yamagishi, M Yoshiyama, K Takeuchi, J Yoshikawa.   

Abstract

BACKGROUND: Intravenous myocardial contrast echocardiography with harmonic power Doppler imaging (HPDI) enables assessment of myocardial perfusion. Its accuracy in comparison with positron emission tomography (PET), which is one of the most reliable clinical gold standards for myocardial perfusion, remains to be determined.
OBJECTIVE: To assess the ability of HPDI to identify myocardial perfusion abnormalities, using PET as a gold standard.
METHODS: 23 patients with myocardial infarction underwent HPDI. Images were obtained from the apical two and four chamber views at pulsing intervals of one to eight cardiac cycles with continuous infusion of Levovist (Schering, Germany). PET was done within two weeks of HPDI. The left ventricle was divided into 12 segments and myocardial opacification by HPDI and uptake of NH(3) by PET in each segment was graded as normal, mildly reduced, or severely reduced.
RESULTS: Of the 276 segments examined, adequate image quality was obtained in 226 (82%) by HPDI; 50 segments were excluded because of inadequate image quality. There were more exclusions in the basal segments than in the mid or apical segments (p < 0.0001). Of the 226 segments analysed, overall concordance between HPDI and PET was 82% (chi = 0.70). In the apex, more segments were overestimated by HPDI than were underestimated (chi(2) = 6.25, p = 0.012).
CONCLUSIONS: HPDI and PET gave similar results in the assessment of myocardial perfusion abnormalities. However, poor image quality in the basal segments and overestimation of perfusion in the apical segments are current limitations of HPDI.

Entities:  

Mesh:

Year:  2003        PMID: 12527662      PMCID: PMC1767560          DOI: 10.1136/heart.89.2.145

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  23 in total

1.  Acoustically stimulated transient power scattering explains enhanced detection of the very low velocities in myocardial capillaries by power Doppler imaging: an in vitro study.

Authors:  T Irvine; S Wanitkun; J Powers; T Shiota; A Kenny; D J Sahn
Journal:  J Am Soc Echocardiogr       Date:  1999-08       Impact factor: 5.251

2.  Assessment of coronary stenosis severity and transmural perfusion gradient by myocardial contrast echocardiography: comparison of gray-scale B-mode with power Doppler imaging.

Authors:  H Masugata; B Cotter; B Peters; K Ohmori; K Mizushige; A N DeMaria
Journal:  Circulation       Date:  2000-09-19       Impact factor: 29.690

3.  Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion.

Authors:  K Wei; A R Jayaweera; S Firoozan; A Linka; D M Skyba; S Kaul
Journal:  Circulation       Date:  1998-02-10       Impact factor: 29.690

4.  Analysis of microvascular integrity, contractile reserve, and myocardial viability after acute myocardial infarction by dobutamine echocardiography and myocardial contrast echocardiography.

Authors:  S Iliceto; L Galiuto; A Marchese; D Cavallari; P Colonna; G Biasco; P Rizzon
Journal:  Am J Cardiol       Date:  1996-03-01       Impact factor: 2.778

5.  Assessment of myocardial perfusion by intermittent harmonic power Doppler using SonoVue, a new ultrasound contrast agent.

Authors:  A Broillet; J Puginier; R Ventrone; M Schneider
Journal:  Invest Radiol       Date:  1998-04       Impact factor: 6.016

6.  Quantification of myocardial perfusion with myocardial contrast echocardiography during left atrial injection of contrast. Implications for venous injection.

Authors:  D M Skyba; A R Jayaweera; N C Goodman; S Ismail; G Camarano; S Kaul
Journal:  Circulation       Date:  1994-09       Impact factor: 29.690

7.  In vivo quantitation of regional myocardial blood flow by positron-emission computed tomography.

Authors:  G Wisenberg; H R Schelbert; E J Hoffman; M E Phelps; G D Robinson; C E Selin; J Child; D Skorton; D E Kuhl
Journal:  Circulation       Date:  1981-06       Impact factor: 29.690

8.  Assessment of myocardial perfusion by harmonic power Doppler imaging at rest and during adenosine stress: comparison with (99m)Tc-sestamibi SPECT imaging.

Authors:  S K Heinle; J Noblin; P Goree-Best; A Mello; G Ravad; S Mull; P Mammen; P A Grayburn
Journal:  Circulation       Date:  2000-07-04       Impact factor: 29.690

9.  Detection of coronary artery stenosis with power Doppler imaging.

Authors:  F S Villanueva; E W Gertz; M Csikari; G Pulido; D Fisher; J Sklenar
Journal:  Circulation       Date:  2001-05-29       Impact factor: 29.690

10.  Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic Q wave infarctions: evidence for persistence of viable tissue in some infarct regions by positron emission tomography.

Authors:  R Brunken; J Tillisch; M Schwaiger; J S Child; R Marshall; M Mandelkern; M E Phelps; H R Schelbert
Journal:  Circulation       Date:  1986-05       Impact factor: 29.690

View more
  3 in total

1.  Novel quantitative assessment of myocardial perfusion by harmonic power Doppler imaging during myocardial contrast echocardiography.

Authors:  S Yamada; K Komuro; T Mikami; N Kudo; H Onozuka; K Goto; S Fujii; K Yamamoto; A Kitabatake
Journal:  Heart       Date:  2005-02       Impact factor: 5.994

2.  Intravenous myocardial contrast echocardiography predicts regional and global left ventricular remodelling after acute myocardial infarction: comparison with low dose dobutamine stress echocardiography.

Authors:  Y Abe; T Muro; Y Sakanoue; R Komatsu; M Otsuka; T Naruko; A Itoh; M Yoshiyama; K Haze; J Yoshikawa
Journal:  Heart       Date:  2005-03-29       Impact factor: 5.994

Review 3.  Non-invasive imaging of microvascular damage.

Authors:  L Galiuto; L Natale; L Leccisotti; G Locorotondo; A Giordano; L Bonomo; F Crea
Journal:  J Nucl Cardiol       Date:  2009-08-25       Impact factor: 5.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.